Medipharm Labs Corp (MLZ)

For some reason they reported twice last week on Monday and Friday. And, with volume for the week down and no change to the SS - this is a material change lol.
It's like or may well even be that Marj got a new boyfriend. The last guy was a bonehead (I believe, if she didn't have that deadbeat

As much as I hate using AI, it is a useful search tool. So, feel free to argue its response, up to you.

The MHRA does not publish, confirm, or acknowledge MAA filings — ever.
So even if a company wanted to make its filing public, there is no public MHRA record to point to.

$RITE Skull Valley tailings project remain ongoing 💯💯💥💥

MineralRite further notes that its previously announced technical evaluation activities relating to the Skull Valley tailings project remain ongoing. Allan L. Schappert, CPG #117

The Numbers are There for a Great ROI.

Please don’t lose hope. I’m as burnt out as you are. This has gone on for too long.

I haven’t lost hope because I know the Numbers.

Yes I’m confident in my calculations.
~27 Billion split 75/25%
2.7X FV

Buy Bitcoin at these bargain prices!!! It’s on sale!!! It’s on sale!! Trust the process!!! Michael Saylor is the man!! And Trump has your back!!!

SS Updated, OS/Unrestricted Increase 1.5B

GTVH Security Details
Share Structure
Market Cap Market Cap
1,735,875
06/03/2026
Authorized Shares
20,000,000,000
06/03/2026
Outstanding Shares
17,358,752,827
06/03/2026

On the financial platform InvestorsHub (iHub), the user "newflow" writes so positively about Washington Mutual (WaMu) escrows primarily because he subscribes to a deeply entrenched and complex conspiracy and speculation theory. Since the historic collapse of Washington Mutual Bank in 2008, certain r

https://www.businesskorea.co.kr/news/articleView.html?idxno=270648
Interesting read

No need to get offensive. You're one of the few I actually read anymore. Don't you think I want you and others to be right about a payout? That's why I post my 100,000 plus qs and ps. Im hoping mid September I'm having to apologize. For now I'm just not feeling it.

You should checkout paint drying and grass growing. Blows vplm away for excitement 😂

You are still assuming the conclusion.
I agree that both items appeared under Licensing. That is not in dispute.

What is in dispute is whether every brain-cancer-related licensing item discussed by CTBVEAG in November must therefore have been DCVax-L.
You keep treating t

Look another beautiful game, he resigned.

https://investorshub.advfn.com/uimage/uploads/2026/6/4/ebgbdScreenshot_2026-06-03_at_9.47.41%E2%80%AFPM.png

87M traded WOW'S MEZ. What's going on here? Max or PEEBOY?

Ballard Power announces results of 2026 Annual General Meeting of ShareholdersJune 4, 2026 12:30 AM
PR Newswire (Canada) class="legendSpanClass"VANCOUVER, BC, class="legendSpanClass"June 4, 2026 /CNW/ - Ballard Power Systems (NASDAQ: BLD

The key question is how large VYVGART sales could become if myositis and Sjögren's disease are eventually approved, because Halozyme earns a royalty on VYVGART Hytrulo sales that use ENHANZE.

Here is a reasonable framework:

Scenario Annual VYVGART Sales Halozyme Royalty

We can agree to disagree on this one because I'm right about this and you're wrong

Totally BS from Grok.

Looks like it was written by JD and his BOD.

Grok doesn’t understand stand the mitigation and the fact that SC forced JD/BOD to settle the “Willful Misconduct” issue with a multiple of the WMB valuation because of the mediation with Judge Lyons.

Too many variables, ultimately the decision is now based on what Blackrock wants for what's best for them and Delfin, especially now that Blackrock is heavily involved.

The most likely reason Halozyme (NASDAQ: HALO) jumped today is that its partner argenx released new positive data on VYVGART (efgartigimod) at the EULAR 2026 medical meeting. The data showed:

Sustained, clinically meaningful benefits in patients with myositis.
Continued positiv

Manganese X Energy Announces Early Exercise of Warrants by Eric SprottJune 4, 2026 12:15 AM
NewsfileMontreal, Quebec--(Newsfile Corp. -

Shares of biopharmaceutical drug delivery company Halozyme Therapeutics (NASDAQ:HALO) jumped 5.2% in the afternoon session after an analyst reiterated a Buy rating on the stock, and a partner company, argenx, presented positive new data for a drug that utilizes Halozyme's technology .Benchmark maint

No need for reverse split if they announce reverse merger. Price will be $10+ well within the required price to uplist

Top 7 Quantum Resistant Crypto Coins in May 2026 https://tangem.com/en/blog/post/quantum-resistant-crypto/